Sleep Apnea, Obstructive study: Standard oral appliance
Official title Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea
ClinicalTrials.gov ID: NCT05497180
What this study is testing
- What it's testing
- This study is testing whether a passive myofunctional appliance can reduce snoring and mild sleep apnea. It also looks at how to pick the right size for each person.
- Who it's for
- You may be able to join if you snore or have mild sleep apnea and want a quick, low‑cost treatment option.
- What's involved
- You will wear a custom‑made mouth device at home. The study will check how well it works and if it causes any side effects.
- Time commitment
- The study lasts a few weeks, with a few visits to fit the device and check your progress.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients diagnosed with mild obstructive sleep apnea or snoring without sleep apnea.
- Patients 18 years or older
- Patients able to provide consent to treatment and participation in the study
You likely can't join if
- Patients previously diagnosed as non-responders to oral appliance therapy for their sleep apnea
- Patients undergoing other active therapies for their sleep apnea
- Patients with a history of airway/sleep breathing surgical interventions
- Participants with a history of airway/sleep breathing surgical intervention are not eligible to be a part of this study do to risk of skewing test...
- Patients with craniofacial, syndromic, or neuromuscular disorders
- Patients with acute medical conditions requiring immediate attention
See the full eligibility criteria
- Patients diagnosed with mild obstructive sleep apnea or snoring without sleep apnea.
- Patients 18 years or older
- Patients able to provide consent to treatment and participation in the study
- Patients previously diagnosed as non-responders to oral appliance therapy for their sleep apnea
- Patients undergoing other active therapies for their sleep apnea
- Patients with a history of airway/sleep breathing surgical interventions
- Participants with a history of airway/sleep breathing surgical intervention are not eligible to be a part of this study do to risk of skewing test results
- Patients with craniofacial, syndromic, or neuromuscular disorders
- Patients with acute medical conditions requiring immediate attention
- Participants with an acute medical problem will be immediately referred to an appropriate physician and will not be allowed to enroll in the study until their health conditions are stable.
The study team makes the final eligibility decision.
Where it is enrolling
- Edmonton, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Edmonton, Alberta, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.